Compile Data Set for Download or QSAR
Found 406 with Last Name = 'johnson' and Initial = 'wl'
TargetCasein kinase II subunit alpha'(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM142829(US8940736, 391)copy SMILEScopy InChI
Affinity DataIC50: 0.0300nMpH: 7.4 T: 2°CAssay Description:The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in th...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2QV3K72US Patent
TargetCasein kinase II subunit alpha'(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM142775(US8940736, 7)copy SMILEScopy InChI
Affinity DataIC50: 0.0700nMpH: 7.4 T: 2°CAssay Description:The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in th...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2QV3K72US Patent
TargetCasein kinase II subunit alpha'(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM142816(US8940736, 281)copy SMILEScopy InChI
Affinity DataIC50: 0.0900nMpH: 7.4 T: 2°CAssay Description:The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in th...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2QV3K72US Patent
TargetCasein kinase II subunit alpha'(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM142774(US8940736, 6)copy SMILEScopy InChI
Affinity DataIC50: 0.0900nMpH: 7.4 T: 2°CAssay Description:The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2QV3K72US Patent
TargetCasein kinase II subunit alpha'(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM142835(US8940736, 402)copy SMILEScopy InChI
Affinity DataIC50: 0.110nMpH: 7.4 T: 2°CAssay Description:The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in th...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2QV3K72US Patent
TargetCasein kinase II subunit alpha'(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM142792(US8940736, 160)copy SMILEScopy InChI
Affinity DataIC50: 0.110nMpH: 7.4 T: 2°CAssay Description:The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in th...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2QV3K72US Patent
TargetCasein kinase II subunit alpha'(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM142777(US8940736, 49)copy SMILEScopy InChI
Affinity DataIC50: 0.110nMpH: 7.4 T: 2°CAssay Description:The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2QV3K72US Patent
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM142829(US8940736, 391)copy SMILEScopy InChI
Affinity DataIC50: 0.130nMpH: 7.4 T: 2°CAssay Description:The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in th...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2QV3K72US Patent
TargetCasein kinase II subunit alpha'(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM142822(US8940736, 328)copy SMILEScopy InChI
Affinity DataIC50: 0.130nMpH: 7.4 T: 2°CAssay Description:The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in th...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2QV3K72US Patent
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM142817(US8940736, 285)copy SMILEScopy InChI
Affinity DataIC50: 0.140nMpH: 7.4 T: 2°CAssay Description:The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in th...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2QV3K72US Patent
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM142774(US8940736, 6)copy SMILEScopy InChI
Affinity DataIC50: 0.150nMpH: 7.4 T: 2°CAssay Description:The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2QV3K72US Patent
TargetCasein kinase II subunit alpha'(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM142784(US8940736, 117)copy SMILEScopy InChI
Affinity DataIC50: 0.150nMpH: 7.4 T: 2°CAssay Description:The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in th...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2QV3K72US Patent
TargetCasein kinase II subunit alpha'(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM142834(US8940736, 399)copy SMILEScopy InChI
Affinity DataIC50: 0.160nMpH: 7.4 T: 2°CAssay Description:The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in th...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2QV3K72US Patent
TargetCasein kinase II subunit alpha'(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM142806(US8940736, 229)copy SMILEScopy InChI
Affinity DataIC50: 0.160nMpH: 7.4 T: 2°CAssay Description:The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in th...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2QV3K72US Patent
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM142835(US8940736, 402)copy SMILEScopy InChI
Affinity DataIC50: 0.160nMpH: 7.4 T: 2°CAssay Description:The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in th...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2QV3K72US Patent
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM142775(US8940736, 7)copy SMILEScopy InChI
Affinity DataIC50: 0.170nMpH: 7.4 T: 2°CAssay Description:The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in th...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2QV3K72US Patent
TargetCasein kinase II subunit alpha'(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM142778(US8940736, 55)copy SMILEScopy InChI
Affinity DataIC50: 0.200nMpH: 7.4 T: 2°CAssay Description:The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in th...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2QV3K72US Patent
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM142793(US8940736, 161)copy SMILEScopy InChI
Affinity DataIC50: 0.210nMpH: 7.4 T: 2°CAssay Description:The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in th...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2QV3K72US Patent
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM142806(US8940736, 229)copy SMILEScopy InChI
Affinity DataIC50: 0.210nMpH: 7.4 T: 2°CAssay Description:The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in th...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2QV3K72US Patent
TargetCasein kinase II subunit alpha'(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM142818(US8940736, 313)copy SMILEScopy InChI
Affinity DataIC50: 0.210nMpH: 7.4 T: 2°CAssay Description:The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in th...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2QV3K72US Patent
TargetCasein kinase II subunit alpha'(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM142832(US8940736, 395)copy SMILEScopy InChI
Affinity DataIC50: 0.210nMpH: 7.4 T: 2°CAssay Description:The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in th...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2QV3K72US Patent
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM142832(US8940736, 395)copy SMILEScopy InChI
Affinity DataIC50: 0.220nMpH: 7.4 T: 2°CAssay Description:The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in th...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2QV3K72US Patent
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM142784(US8940736, 117)copy SMILEScopy InChI
Affinity DataIC50: 0.220nMpH: 7.4 T: 2°CAssay Description:The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in th...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2QV3K72US Patent
LigandPNGBDBM50552696(CHEMBL4778959)copy SMILES
Affinity DataIC50: 0.220nMAssay Description:Inhibition of recombinant human N-terminal GST-tagged HPK1 (1 to 346 residues) expressed in baculovirus infected Sf9 cells using NH2-fluorescein-RFAR...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DN48N7PubMed
TargetCasein kinase II subunit alpha'(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM142836(US8940736, 408)copy SMILEScopy InChI
Affinity DataIC50: 0.230nMpH: 7.4 T: 2°CAssay Description:The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in th...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2QV3K72US Patent
TargetCasein kinase II subunit alpha'(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM142802(US8940736, 207)copy SMILEScopy InChI
Affinity DataIC50: 0.230nMpH: 7.4 T: 2°CAssay Description:The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in th...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2QV3K72US Patent
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM142834(US8940736, 399)copy SMILEScopy InChI
Affinity DataIC50: 0.230nMpH: 7.4 T: 2°CAssay Description:The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in th...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2QV3K72US Patent
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM142777(US8940736, 49)copy SMILEScopy InChI
Affinity DataIC50: 0.230nMpH: 7.4 T: 2°CAssay Description:The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2QV3K72US Patent
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM142792(US8940736, 160)copy SMILEScopy InChI
Affinity DataIC50: 0.240nMpH: 7.4 T: 2°CAssay Description:The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in th...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2QV3K72US Patent
TargetCasein kinase II subunit alpha'(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM142820(US8940736, 319)copy SMILEScopy InChI
Affinity DataIC50: 0.25nMpH: 7.4 T: 2°CAssay Description:The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in th...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2QV3K72US Patent
TargetCasein kinase II subunit alpha'(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM142799(US8940736, 179)copy SMILEScopy InChI
Affinity DataIC50: 0.260nMpH: 7.4 T: 2°CAssay Description:The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in th...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2QV3K72US Patent
TargetCasein kinase II subunit alpha'(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM142831(US8940736, 394)copy SMILEScopy InChI
Affinity DataIC50: 0.270nMpH: 7.4 T: 2°CAssay Description:The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in th...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2QV3K72US Patent
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM142831(US8940736, 394)copy SMILEScopy InChI
Affinity DataIC50: 0.270nMpH: 7.4 T: 2°CAssay Description:The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in th...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2QV3K72US Patent
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM142794(US8940736, 163)copy SMILEScopy InChI
Affinity DataIC50: 0.270nMpH: 7.4 T: 2°CAssay Description:The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in th...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2QV3K72US Patent
TargetCasein kinase II subunit alpha'(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM142796(US8940736, 173)copy SMILEScopy InChI
Affinity DataIC50: 0.270nMpH: 7.4 T: 2°CAssay Description:The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in th...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2QV3K72US Patent
TargetCasein kinase II subunit alpha'(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM142795(US8940736, 167)copy SMILEScopy InChI
Affinity DataIC50: 0.270nMpH: 7.4 T: 2°CAssay Description:The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in th...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2QV3K72US Patent
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM142816(US8940736, 281)copy SMILEScopy InChI
Affinity DataIC50: 0.270nMpH: 7.4 T: 2°CAssay Description:The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in th...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2QV3K72US Patent
TargetCasein kinase II subunit alpha'(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM142807(US8940736, 238)copy SMILEScopy InChI
Affinity DataIC50: 0.270nMpH: 7.4 T: 2°CAssay Description:The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in th...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2QV3K72US Patent
LigandPNGBDBM50552697(CHEMBL4780798)copy SMILES
Affinity DataIC50: 0.280nMAssay Description:Inhibition of recombinant human N-terminal GST-tagged HPK1 (1 to 346 residues) expressed in baculovirus infected Sf9 cells using NH2-fluorescein-RFAR...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DN48N7PubMed
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM142820(US8940736, 319)copy SMILEScopy InChI
Affinity DataIC50: 0.280nMpH: 7.4 T: 2°CAssay Description:The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in th...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2QV3K72US Patent
TargetCasein kinase II subunit alpha'(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM142779(US8940736, 57)copy SMILEScopy InChI
Affinity DataIC50: 0.280nMpH: 7.4 T: 2°CAssay Description:The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in th...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2QV3K72US Patent
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM142778(US8940736, 55)copy SMILEScopy InChI
Affinity DataIC50: 0.290nMpH: 7.4 T: 2°CAssay Description:The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in th...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2QV3K72US Patent
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM142818(US8940736, 313)copy SMILEScopy InChI
Affinity DataIC50: 0.290nMpH: 7.4 T: 2°CAssay Description:The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in th...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2QV3K72US Patent
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM142795(US8940736, 167)copy SMILEScopy InChI
Affinity DataIC50: 0.300nMpH: 7.4 T: 2°CAssay Description:The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in th...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2QV3K72US Patent
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM142779(US8940736, 57)copy SMILEScopy InChI
Affinity DataIC50: 0.300nMpH: 7.4 T: 2°CAssay Description:The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in th...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2QV3K72US Patent
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM142790(US8940736, 133)copy SMILEScopy InChI
Affinity DataIC50: 0.300nMpH: 7.4 T: 2°CAssay Description:The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in th...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2QV3K72US Patent
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM142802(US8940736, 207)copy SMILEScopy InChI
Affinity DataIC50: 0.310nMpH: 7.4 T: 2°CAssay Description:The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in th...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2QV3K72US Patent
TargetCasein kinase II subunit alpha'(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM142793(US8940736, 161)copy SMILEScopy InChI
Affinity DataIC50: 0.310nMpH: 7.4 T: 2°CAssay Description:The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in th...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2QV3K72US Patent
TargetCasein kinase II subunit alpha'(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM142797(US8940736, 174)copy SMILEScopy InChI
Affinity DataIC50: 0.350nMpH: 7.4 T: 2°CAssay Description:The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in th...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2QV3K72US Patent
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM142827(US8940736, 382)copy SMILEScopy InChI
Affinity DataIC50: 0.390nMpH: 7.4 T: 2°CAssay Description:The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2QV3K72US Patent
Displayed 1 to 50 (of 406 total ) | Next | Last >>
Jump to: